Search Results - Holger N. Lode

  • Showing 1 - 7 results of 7
Refine Results
  1. 1

    DNA Vaccination: Using the Patient's Immune System to Overcome Cancer by Georg Eschenburg, Alexander Stermann, Robert Preissner, Hellmuth-Alexander Meyer, Holger N. Lode

    Published in Clinical and Developmental Immunology (2010-01-01)
    Get full text
    Article


  2. 2

    Generation and Characterization of a Human/Mouse Chimeric GD2-Mimicking Anti-Idiotype Antibody Ganglidiximab for Active Immunotherapy against Neuroblastoma. by Christin Eger, Nikolai Siebert, Diana Seidel, Maxi Zumpe, Madlen Jüttner, Sven Brandt, Hans-Peter Müller, Holger N Lode

    Published in PLoS ONE (2016-01-01)
    Get full text
    Article


  3. 3

    Triage through telemedicine in paediatric emergency care-Results of a concordance study. by Angelika Beyer, Kilson Moon, Peter Penndorf, Thomas Hirsch, Uta Zahn-Tesch, Wolfgang Hoffmann, Holger N Lode, Neeltje van den Berg

    Published in PLoS ONE (2022-01-01)
    Get full text
    Article


  4. 4

    GD2-directed bispecific trifunctional antibody outperforms dinutuximab beta in a murine model for aggressive metastasized neuroblastoma by Annette Künkele, Angelika Eggert, Johannes H Schulte, Anika Klaus, Horst Lindhofer, Felix Zirngibl, Sara M Ivasko, Laura Grunewald, Silke Schwiebert, Peter Ruf, Kathy Astrahantseff, Lena Andersch, Holger N Lode, Kathleen Anders, Patrick Hundsdoerfer

    Published in Journal for ImmunoTherapy of Cancer (2021-07-01)
    Get full text
    Article


  5. 5

    CDK inhibitors promote neuroblastoma cell differentiation and increase sensitivity to retinoic acid—a promising combination strategy for therapeutic intervention by Fatemeh Shokraie, Larissa Lechermeier, Pia Bordihn, Philipp Kaps, Steffen Möller, Anna Sophie Schulz, Björn Schneider, Dirk Koczan, Samira Khanipour Roshan, Holger N. Lode, Carl-Friedrich Classen, Olga Hahn, Sascha Troschke-Meurer, Claudia Maletzki

    Published in Cell Death Discovery (2025-08-01)
    Get full text
    Article


  6. 6

    Combination of GD2-directed bispecific trifunctional antibody therapy with Pd-1 immune checkpoint blockade induces anti-neuroblastoma immunity in a syngeneic mouse model by Sara Marie Ivasko, Sara Marie Ivasko, Kathleen Anders, Kathleen Anders, Laura Grunewald, Michael Launspach, Michael Launspach, Anika Klaus, Silke Schwiebert, Peter Ruf, Horst Lindhofer, Holger N. Lode, Lena Andersch, Johannes H. Schulte, Johannes H. Schulte, Johannes H. Schulte, Angelika Eggert, Angelika Eggert, Angelika Eggert, Patrick Hundsdoerfer, Patrick Hundsdoerfer, Annette Künkele, Annette Künkele, Annette Künkele, Annette Künkele, Felix Zirngibl, Felix Zirngibl

    Published in Frontiers in Immunology (2023-01-01)
    Get full text
    Article


  7. 7

    Copper chelation redirects neutrophil function to enhance anti-GD2 antibody therapy in neuroblastoma by Jourdin R. C. Rouaen, Antonietta Salerno, Tyler Shai-Hee, Jayne E. Murray, Giulia Castrogiovanni, Charlotte McHenry, Toni Rose Jue, Vu Pham, Jessica Lilian Bell, Ensieh Poursani, Emanuele Valli, Riccardo Cazzoli, Naomi Damstra, Delia J. Nelson, Kofi L. P. Stevens, Jonathan Chee, Iveta Slapetova, Maria Kasherman, Renee Whan, Francis Lin, Blake J. Cochran, Nicodemus Tedla, Feyza Colakoglu Veli, Aysen Yuksel, Chelsea Mayoh, Federica Saletta, Daniele Mercatelli, Tatyana Chtanova, Arutha Kulasinghe, Daniel Catchpoole, Giuseppe Cirillo, Maté Biro, Holger N. Lode, Fabio Luciani, Michelle Haber, Juliet C. Gray, Toby N. Trahair, Orazio Vittorio

    Published in Nature Communications (2024-12-01)
    Get full text
    Article


Search Tools: